Effect of age on cerebrospinal fluid levels of metabolites of biopterin and biogenic amines

Acta Paediatrica, International Journal of Paediatrics

Volumn 88, Issue 12, 1999, Pages 1344-1347

  Komori, H ^a   Matsuishi, T ^a   Yamada, S ^a   Ueda, N ^a   Yamashita, Y ^a   Kato, H ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

5 hydroxyindoleacetic acid; Biopterin; Cerebrospinal fluid; Homovanillic acid; Tetrahydrobiopterin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; BIOGENIC AMINE; BIOPTERIN; HOMOVANILLIC ACID;

ADOLESCENT; ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CHILD; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PARKINSON DISEASE; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; REGRESSION ANALYSIS; SCHOOL CHILD;

EID: 0033385113     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1999.tb01048.x     Document Type: Article

References (14)

1. 1. Nagatsu T, Matsuura S, Sugimoto T. Physiological and clinical chemistry of biopterin. Med Res Rev 1989; 9: 25-44
2. 2. Furukawa Y, Kondo T, Nishi K, Yokochi F, Narabayashi H. Total biopterin levels in the ventricular CSF of patients with Parkinson's disease: a comparison between akineto-rigid and tremor types. J Neurol Sci 1991; 103: 232-7
3. 3. Dissing IC, Guttler F, Pakkenberg H, Lou H, Gerdes AM, Lykkelund C, et al. Tetrahydrobiopterin and Parkinson's disease. Acta Neurol Scand 1989; 79: 493-9
4. 4. Kay AD, Milstien S, Kaufman S, Creasey H, Haxby JV, Cutler NR, et al. Cerebrospinal fluid biopterin is decreased in Alzheimer's disease. Arch Neurol 1986; 43: 996-9
5. 5. Fink JK, Ravin P, Argoff CE, Levine RA, Brady RO, Hallett M, et al. Tetrahydrobiopterin administration in biopterin-deficient progressive dystonia with diurnal variation. Neurology 1989; 39: 1393-5
6. 6. Tani Y, Fernell E, Watanabe Y, Kanal T, Langstrom B. Decrease in 6R-5,6,7,8-tetrahydrobiopterin content in cerebrospinal fluid of autistic patients. Neurosci Lett 1994; 181: 169-72
7. 7. Komori H, Matsuishi T, Yamada S, Ichikawa K, Amamoto M, Yamashita F. Elevated biopterin and homovanillic acid levels in cerebrospinal fluid from children with aseptic meningitis. J Child Neurol 1994; 9: 22-5
8. 8. Zoghbi HY, Milstien S, Butler IJ, Smith EO, Kaufman S, Glaze DG, et al. Cerebrospinal fluid biogenic amines and biopterin in Rett syndrome. Ann Neurol 1989; 25: 56-60
9. 9. Hyland K, Surtees RA, Heales SJ, Bowron A, Howells DW, Smith I. Cerebrospinal fluid concentrations of pterins and metabolites of serotonin and dopamine in a pediatric reference population. Pediatr Res 1993; 34: 10-4
10. 10. Seifert WE Jr, Foxx JL, Butler IJ. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid. Ann Neurol 1980; 8: 38-42
11. 11. Langlais PJ, Walsh FX, Bird ED, Levy HL. Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children. Pediatrics 1985; 75: 580-6
12. 12. Blennow K, Wallin A, Gottfries CG, Karlsson I, Mansson JE, Skoog I, et al. Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18-88 years of age. Eur Neuropsychopharmacol 1993; 3: 55-61
13. 13. Allanson J, McInnes R, Bradley L, Tarby T, Naylor E, Nardella M. Combined transient and peripheral defects in tetrahydrobiopterin synthesis. J Pediatr 1991; 118: 261-3
14. 14. Sladek JR Jr, Blanchard B, Collier TJ, Elsworth JD, Taylor JR, Roth RH, et al. Development of mesencephalic dopamine neurons in the nonhuman primate. In: Boom FE, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1995: 269-82